Across the world, many women are turning away from IUDs (coils) because of reports of intense pain during insertion, even though IUDs are among the most effective and long‑acting contraceptive methods available.
Research shows that fear of pain and previous negative stories often shared on social media are major barriers to IUD uptake, particularly for adolescents, young adults and women who have never given birth.
Clinical studies confirm that most patients feel some degree of pain, and that those who are nulliparous, highly anxious, or have had difficult gynecologic experiences in the past are more likely to experience severe pain. At the same time, reviews repeatedly highlight a striking problem: there is still no universal standard of care for IUD pain management, leading to wide variation between clinics and individual providers
Many women are simply told to take ibuprofen, despite systematic reviews showing that routine NSAIDs offer little or no meaningful relief during insertion for most patients. This mismatch between women’s lived experiences and the minimal pain control they are offered feeds mistrust and discourages the use of a highly effective contraceptive option.
Researchers and clinicians increasingly argue that women deserve adequate pain relief, informed consent and genuinely sensitive care when choosing an IUD. Evidence‑based options now include local anesthetic techniques such as paracervical lidocaine block which network meta‑analysis and guidelines identify as one of the most effective ways to reduce pain as well as topical lidocaine sprays and creams, cervical priming with prostaglandins like misoprostol or dinoprostone in selected cases, and targeted use of naproxen for post‑procedure cramping.
Beyond drugs, best‑practice recommendations emphasize a client centred, trauma‑informed approach: clear pre‑insertion counseling, realistic discussion of possible pain, active listening to fears, “verbal analgesia,” distraction techniques, and creating a calm, respectful environment.
Patient surveys show that women value explanations of each step, honest conversations about pain, and providers who acknowledge rather than minimize their discomfort factors that strongly predict satisfaction, even when some pain remains.
Yet audits and surveys reveal that many providers still do not routinely offer analgesia, and some assume the pain is “short‑lived” or “minimal,” revealing a disconnect between clinical culture and women’s expectations.
As medical experts call for better pain protocols, more education and updated guidelines, the message from current research is clear: taking women’s IUD pain seriously is not optional it is central to high‑quality, ethical reproductive healthcare